Menu
Categories: , ,
CATALOG #:1005-PP-007

Influenza H7 Pseudovirus

Lentivirus vector pseudotyped with Influenza H7 hemagglutinin. Lentiviral vectors are self-inactivating (SIN), and thus restrict mRNA production from integrating vectors to the internal promoter, severely reducing full-length vector transcripts. Infectivity and neutralization of infectivity can be measured by luciferase activity.
  • Formulation & Storage: Supplied in phosphate buffered saline (PBS). Store at -80°C, avoid freeze/thaw cycles.
  • Titer Estimate*: 2.2 x 105 RLU/µL
  • Usage Estimates*: Approximately 1 mL can be used to perform 2,,000 reactions or 20 x 96-well plates.
  • Reporter: Luciferase
Please email products@integratedbiotherapeutics.com for lot specific information for ‘Titer’ and ‘Usage’.

Additional information

Size

Sufficient for one 96-well plate

Download:

$1,294.00

OVERVIEW

PRODUCT NAME

Influenza H7 Pseudovirus

PRODUCT TARGET

Avian Influenza H7 Pseudovirus

PRODUCT ABBREVIATION

Avian Influenza H7 Pseudovirus

PATHOGEN STRAIN

A/Shanghai/4664T/2013

TARGET PATHOGEN

A/Shanghai/4664T/2013

PRODUCT CATEGORY

, ,

PRODUCT TYPE

Pseudovirus

PURIFICATION

EXPRESSION

HEK-293T cells

APPLICATIONS

Neutralization

PROPERTIES

Form

Liquid

Clone number

Liquid

ISOTYPE

Liquid

Clonality

Liquid

Purity

Liquid

Storage buffer

pH: 7.20 Preservative: 0.1% Sodium azide Constituents: 1% BSA, PBS

Concentration

Batch dependent within range: 100 µl at 0.029 - 0.031 mg/ml
Batch dependent within range: 1 ml at 0.03 - 0.031 mg/ml
Batch dependent within range: 500 µl at 0.03 - 1.154 mg/ml

Research areas

Cell Biology | Cell Cycle | Markers | Neuroscience | Cell Type Marker | Neuron marker | Soma marker | Tags & Cell Markers | Cell Type Markers Replication | Neuroscience Neurology process Neurogenesis | Cancer Cell cycle | Cell division | Cancer | Tumor biomarkers | Other | Neuroscience | Development

Concentration

Batch dependent within range: 100 µl at 0.029 - 0.031 mg/ml
Batch dependent within range: 1 ml at 0.03 - 0.031 mg/ml
Batch dependent within range: 500 µl at 0.03 - 1.154 mg/ml

Form Formulation Storage Concentration
Liquid Supplied in PBS -80°C Batch dependent

DATASHEET AND PROTOCOLS

DOWNLOAD DATASHEET

REFRENCES

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea 

REFRENCE NUMBER: 22050

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea 

REFRENCE NUMBER: 22050

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea 

REFRENCE NUMBER: 22050

CUSTOMER Q&A

All orders can be placed via our website using credit card or by submitting a purchase order (PO) to services@ibtbioservices.com. If you use your account login to purchase any products, POs can be directly uploaded during checkout. Please call us at (877) 411-2041 to make a payment using a credit card OR Credit Card payments can be made via our website OR you can call us at (877) 411-2041 to make a payment using a credit card.
Our standard payment term is NET30.
Yes, standard sales taxes apply. If you are a tax-exempt organization, please provide us with your tax-exempt certificate and your invoice will be adjusted accordingly.

Please contact us at services@ibtbioservices.com for bulk orders discounts and shipping timelines. 

Shortly after your order has been successfully submitted online through our storefront, you should receive an order confirmation to your email from our automated system. If you have placed the order with our product representative, all details will be provided via email.

To explore potential career opportunities with us please navigate to the Careers section of our webpage where you will find a list of current job openings, each accompanied by detailed job descriptions and application instructions. IBT is an equal opportunity employer.
To explore potential career opportunities with us please navigate to the Careers section of our webpage where you will find a list of current job openings, each accompanied by detailed job descriptions and application instructions. IBT is an equal opportunity employer.
Items are shipped through FedEx International Priority Express with delivery within 2-3 days. Delivery time may vary depending on each country’s customs process. Any international order that is received/processed after Wednesday at 1:00pm (EST) will be shipped on the following Monday. For shipments to Europe, Japan and Korea, please contact our authorized distributors for your territory.
  • Product defects or Quality Issues: 

For concerns regarding quality issues unrelated to temperature, customers may request a return or exchange within 7 days of receipt. Our quality control team will assess the returned items, and upon confirmation of the issue, a decision will be made to replace the product or issue a refund. 

  • Exchanges for Incorrectly Ordered Items: 

If customers mistakenly order the wrong reagent, we may consider exchanges under certain conditions. Items that have not yet been shipped or unopened packages can be exchanged. The customer will be responsible for shipping costs. 

  • Return Authorization Process: 

To initiate a return or exchange, customers must contact our Product Representatives team at services@IBTBioservices.com.  

Note: All returns/exchanges must be shipped back within 7 days of notifying our product representatives about the issue. We reserve the right to refuse returns that do not meet the specified conditions outlined in this policy.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

YOU MAY ALSO BE INTERESTED IN

Related products

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Mu (B.1.621)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta (B.1.617.2)

A monolayer of Vero cells is infected with VLPs or a mixture of VLPs and test sample for approximately 1 hr in a dilution block. Cells are overlayed with 1-2% FBS supplemented media and incubated overnight at 37°C + 5% CO2. Following overnight incubation, luciferase activity is measured by adding an appropriate substrate like Bright-Glo™ or Luciferase Assay System (Promega). Plates can be read immediately on an instrument such as BioTek Cytation™ or similar. Relative neutralization activity is measured by comparing treated versus untreated wells (or virus only control). In dose response experiments the concentration of TA resulting in 50% neutralization (IC50) is determined. Repeated freeze/thaw cycles are not recommended as it may affect viral titer and infectivity.

SARS-CoV-2, Virus Like Particles (Wild Type)

Viral Titration: Serially diluted pseudoviruses in EMEM™ in a 2-fold series were added to Vero cells seeded in a 96-well plate at a seeding density of 6E4 cells/well. Cells with media alone were used as control. After 24 h, the infection was monitored using the Luciferase Assay System (Promega, Madison, WI, USA). Viral titer was calculated using a dilution that resulted in a Relative Luciferase Unit (RLU). The RLU value recommended for this product is based readout from the BioTek Cytation™ instrument. Absolute RLU obtained by the user may vary based on the user’s instrument & handling or luciferase assay system

rVSV pseudotyped Marburg Virus GP (Angola Strain)

Viral Titration: Serially diluted pseudoviruses in EMEM™ in a 2-fold series were added to Vero cells seeded in a 96-well plate at a seeding density of 6E4 cells/well. Cells with media alone were used as control. After 24 h, the infection was monitored using the Luciferase Assay System (Promega, Madison, WI, USA). Viral titer was calculated using a dilution that resulted in a Relative Luciferase Unit (RLU). The RLU value recommended for this product is based readout from the BioTek Cytation™ instrument. Absolute RLU obtained by the user may vary based on the user’s instrument & handling or luciferase assay system.

rVSV-pseudotyped Ebola virus GP (rVSV-EBOV-GP)

Influenza H5 Pseudovirus

Influenza H7 Pseudovirus

Influenza Hemagglutinin GP (H10N8) minus transmembrane region: SDS-PAGE and Western Blot Data: (A) SDS-PAGE of rHAΔTM under reduced condition: 1 µg and 5 µg (Lanes 1 and 2 respectively). (B) Western blot detection of rHA at 50 ng (Lane 1), using an anti-HA (H10N3) polyclonal antibody at 0.5 µg/mL and an anti-rabbit IgG-HRP conjugate, followed by TMB membrane substrate.

Influenza Hemagglutinin Glycoprotein (H3N2) – A/Wisconsin/67/2005

Nipah Attachment F protein: SDS-PAGE and Western Blot Data: (A) SDS-PAGE and stain demonstrating 1 µg and 3 µg (Lanes 1 and 2 respectively) of NiVBF His-tag under denaturing and reducing conditions. MW denotes Novex® Sharp prestained protein marker. (B) Western blot detection of NiVBF His-tag at 200 ng (Lane 3) using a mouse Penta-His antibody at 0.2 g/mL, followed by anti-mouse IgG-HRP conjugate and visualized using TMB membrane substrate.

Nipah Virus Attachment F

Viral Titration: Serially diluted pseudoviruses in EMEM™ in a 2-fold series were added to Vero cells seeded in a 96-well plate at a seeding density of 6E4 cells/well. Cells with media alone were used as control. After 24 h, the infection was monitored using the Luciferase Assay System (Promega, Madison, WI, USA). Viral titer was calculated using a dilution that resulted in a Relative Luciferase Unit (RLU). The RLU value recommended for this product is based readout from the BioTek Cytation™ instrument. Absolute RLU obtained by the user may vary based on the user’s instrument & handling or luciferase assay system

rVSV pseudotyped Sudan Virus GP (Gulu Strain)

Venezuelan Equine Encephalitis Virus (VEEV) E3E2 GP: SDS-PAGE and Western Blot Data: (A) SDS-PAGE and stain demonstrating 1 µg (Lanes 1 and 3 respectively) and 3µg(Lanes 2 and 4 respectively) of VEEV E3E2 HA-Tag protein under denaturing and reducing conditions (Lanes 1 and 2 respectively) and under denaturing and non-reducing conditions. M denotes Novex Sharp prestained protein markers. (B) Western blot detection of VEEV E3E2 1 µg. Lane 5 under denaturing and reducing conditions and line 6 under denaturing and non-reducing conditions. VEEV E3E2 protein was detected using primary THE TM His Tag Monoclonal Antibody 1:1000 (GenScript, Catalog #A00186) and secondary Goat anti-mouse IgG-HRP conjugate 1:3000 (KPL Cat#54500001), followed by TMB substrate.

Venezuelan Equine Encephalitis Virus (VEEV) E3E2 GP Recombinant Protein (His-tagged)

test product

SARS-CoV-2 Indicator Cell Line for RNA Replication – GFP Reporter only

Ebola virus-like particles (EBOV VLP): Western Blot was used to confirm the presence of EBOV-specific GP, NP and VP40 in the VLP. VLP sample was heat-denatured under reducing condition and loaded at 1 µg/lane. (A) GP was detected as a broadly-diffused band 60-110 kDa using 50 ng/mL of anti-EBOV GP rabbit Pab (cat# 0301-015) (B) NP was detected as a single sharp band at ~90 kDa using 100 ng/mL of anti-EBOV NP rabbit Pab (cat# 0301-012) (C) VP40 was detected as a single sharp band at ~40 kDa using 50 ng/mL of anti-EBOV VP40 rabbit Pab (cat# 0301-010)

Ebola virus-like particles (EBOV VLP) (Zaire)

HIV Virus like particle

HIV Virus like particle (Human Immunodeficiency Virus)

Search
Generic filters

Choice Billing Address

×

You have no billing addresses.

Choice Shipping Address

×